6B9Z
Trastuzumab Fab v3
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRL BEAMLINE BL9-2 |
Synchrotron site | SSRL |
Beamline | BL9-2 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2017-04-06 |
Detector | DECTRIS PILATUS3 S 6M |
Wavelength(s) | 0.97946 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 53.490, 105.290, 117.150 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 39.500 - 1.820 |
R-factor | 0.166 |
Rwork | 0.165 |
R-free | 0.18900 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4ioi |
RMSD bond length | 0.006 |
RMSD bond angle | 0.840 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX (1.11.1_2575) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 39.500 | 1.870 |
High resolution limit [Å] | 1.820 | 1.820 |
Rmerge | 0.075 | 0.760 |
Number of reflections | 59094 | |
<I/σ(I)> | 16.8 | |
Completeness [%] | 98.3 | 98 |
Redundancy | 13.5 | 14 |
CC(1/2) | 0.999 | 0.657 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.1 M Tris, pH 7.5, 24 mM NaCl, 15% PEG3350 |